Pharmax Journey

Pharmax History

Pharmaxat a Glance Headquartered in Dubai, United Arab Emirates, Pharmax is a EU GMP-licensed and marketers of affordable high quality medications in MENA region. Geographical Presence: MENA region. Number of Employees: 73 A diversied products portfolio covering a wide

range of therapeutical areas. PharmaxFinancial Stability Pharmax Pharmaceuticals , a group company of ADQ, one of the region’s largest holding companies with direct and indirect investments in more than 90 compan...

Read more
Read more

A Word from Our CEO

“At Pharmax Pharmaceuticals, we put quality first. Every employee at Pharmax works in collaboration to ensure our efficacious medications are produced to the highest standard.

Quality culture is the core element of Pharmax Pharmaceuticals, enabling us to achieve our vision of ‘Maximum Health’. We are in the business of manufacturing and commercializing high quality, safe, efficacious, and cost effective pharmaceutical products that exceed our patients and customer expectations. We strive to maintain effective quality management systems, efficient processes, and quality focused behaviours of qualified and skilled personnel, adhering to cGMP requirements.”

Madhukar Tanna, Chief Executive Officer

Pharmax Brands

Open for Partnerships

We believe in entering partnerships with global players for the expansion of our product portfolio, acquisition of unique drug delivery technologies or for specific dossiers that can meet our commercial plans. We strive for long term strong partnerships with suppliers, distributors, and customers through providing contracts manufacturing services offering products through distribution deals, as well as offering products through out- licensing and in-licensing. To discuss further, please contact us on info@pharmax.ae

Contact Us

Latest News & Blogs VIEW ALL

Copyright 2021 – Pharmax Pharmaceuticals FZ-LLC. All Rights Reserved.

Ministry of Health Health and Prevention Advertisement License No : UNGQQ48S-100821 and its validity until 10/08/2022.

CLICK HERE TO ENTER